The Korean Journal of Applied Statistics (응용통계연구)

The Korean Statistical Society (한국통계학회)
권호 표지
DOI QR코드

DOI QR Code

Analysis of stage III stomach cancer using the restricted mean survival time

제한된 평균 생존시간을 이용한 위암 3기 자료 분석에 관한 연구

  • Kim, Bitna (Department of Statistics, Kangwon National University) ;
  • Lee, Minjung (Department of Statistics, Kangwon National University)
  • Received : 2020.12.22
  • Accepted : 2021.02.22
  • Published : 2021.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

The purpose of this study is to compare the effects of treatment on stage III stomach cancer data obtained from the SEER program of the National Cancer Institute and to identify the significant risk factors for the survival rates of stage III stomach cancer. Since the proportional hazards assumption was violated for treatment, we used the restricted mean survival time as an alternative to the proportional hazards model. The restricted mean survival time was estimated using pseudo-observations, and the effects of treatment were compared using a test statistic based on the estimated restricted mean survival times. We conducted the regression analysis using a generalized linear model to investigate the significant predictors for the restricted mean survival time of patients with stage III stomach cancer. We found that there was a significant difference between the restricted mean survival times of treatment groups. Age at diagnosis, race, substage, grade, tumor size, surgery, and treatment were significant predictors for the restricted mean survival time of patients with stage III stomach cancer. Surgery was the most significant predictor for increasing the restricted mean survival time of patients with stage III stomach cancer.

본 연구는 미국 국립암연구소의 SEER 프로그램에서 제공하는 위암 3기 자료에 대해 항암치료의 효과를 비교하고 위암 생존율에 유의한 영향을 미치는 요인을 알아보고자 한다. 본 연구에서 분석한 위암 3기 자료는 비례위험 가정이 성립하지 않아 대안으로 제한된 평균 생존시간을 이용한 분석 방법을 자료 분석에 적용하였다. 의사-관측들을 이용하여 제한된 평균 생존시간을 추정하였고, 제한된 평균 생존시간 추정량에 기반한 검정통계량을 이용하여 항암치료의 효과를 파악하였다. 일반화 선형모형을 이용한 회귀모형을 통해 위암 3기 환자의 평균 생존시간에 유의한 영향을 미치는 공변량들의 효과를 추정하였다. 항암치료법에 따라 위암 3기 환자의 평균 생존시간에 유의한 차이가 있음을 확인하였고, 진단연령, 인종, 세분화병기, 분화도, 종양의 크기, 수술여부, 항암치료가 위암 3기 환자의 평균 생존시간에 유의한 영향을 미치는 요인들이였으며, 그 중 수술여부가 위암 3기 환자의 평균 생존시간을 늘리는데 가장 큰 영향을 미치는 요인임을 확인하였다.

Keywords

Acknowledgement

이 논문은 2018년도 정부(교육부)의 재원으로 한국연구재단의 지원을 받아 수행된 기초연구사업임 (NRF-2018R1D1A1B07041070).

References

  1. Andersen PK, Hansen MG, and Klein JP (2004). Regression analysis of restricted mean survival time based on pseudo-observations, Lifetime Data Analysis, 10, 335-350. https://doi.org/10.1007/s10985-004-4771-0
  2. Andersen PK and Perme MP (2010). Pseudo-observations in survival analysis, Statistical Methods in Medical Research, 19, 71-99. https://doi.org/10.1177/0962280209105020
  3. Chen PY and Tsiatis AA (2001). Causal inference on the difference of the restricted mean lifetime between two groups, Biometrics, 57, 1030-1038. https://doi.org/10.1111/j.0006-341X.2001.01030.x
  4. Cox DR (1972). Regression models and life-tables (with discussion), Journal of Royal Statistical Society, Series A, 34, 187-220.
  5. Grambsch P and Therneau T (1994). Proportional hazards tests and diagnostics based on weighted residuals, Biometrika, 81 ,515-526. https://doi.org/10.1093/biomet/81.3.515
  6. Guo C and Liang Y (2019). Analyzing restricted mean survival time using SAS/STAT, SAS Institute Inc., Cary, NC.
  7. Irwin JO (1949). The standard error of an estimate of expectation of life, with special reference to expectation of tumourless life in experiments with mice, The Journal of Hygiene, 47, 188-189. https://doi.org/10.1017/S0022172400014443
  8. Kaplan EL and Meier P (1958). Nonparametric estimation from incomplete observations, Journal of the American Statistical Association, 53, 457-481. https://doi.org/10.1080/01621459.1958.10501452
  9. Korea Central Cancer Registry (2019). National cancer center, Annual report of cancer statistics in Korea in 2017, Ministry of health and welfare.
  10. Liang KY and Zeger SL (1986). Longitudinal data analysis using generalized linear models, Biometrika, 73, 13-22. https://doi.org/10.1093/biomet/73.1.13
  11. National Cancer Information Center (2019). Cancer information service. from: https://www.cancer.go.kr/
  12. Nemes S, Bulow E, and Gustavsson A (2020). A brief overview of restricted mean survival time estimators and associated variances, MDPI Stats, 3, 107-119.
  13. Prentice RL (1978). Linear rank tests with right censored data, Biometrike, 65, 167-180. https://doi.org/10.1093/biomet/65.1.167
  14. Royston P and Parmar MK (2011). The use of restricted mean survival time to estimate the treatment effect in randomized clinical trials when the proportional hazards assumption is in doubt, Statistics in Medicine, 30, 2409-2421. https://doi.org/10.1002/sim.4274
  15. Ruhl J, Ward E, Hofferkamp J, et al (2019). Grade Manual. NAACCR, Springfield, IL 62704-4194.
  16. Schoenfeld D (1982). Partial residuals for the proportional hazards regression model, Biometrika, 69, 239-241. https://doi.org/10.1093/biomet/69.1.239
  17. Surveillance, Epidemiology, and End results (SEER) program (www.seer.cancer.gov) SEER*Stat Database : Incidence - SEER 18 Regs custom data (with additional treatment fields), Nov 2018 Sub (1975-2016 varying) - Linked to county attributes - total US, 1969-2017 counties, national cancer institute, DCCPS, Surveillance research program, released April 2019, based on the November 2018 submission.
  18. Tian L, Zhao L, and Wei LJ (2014). Predicting the Restricted mean event time with the subject's baseline covariates in survival analysis, Biostatistics, 15, 222-233. https://doi.org/10.1093/biostatistics/kxt050
  19. Zeger SL and Liang KY (1986). Longitudinal data analysis for discrete and continuous outcomes, Biometrics, 42, 121-130. https://doi.org/10.2307/2531248
  20. Zhao L, Tian L, Uno H, Solomon SD, Pfeffer MA, Schindler JS, and Wei LJ (2012). Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study, Clinical Trials, 9, 570-577. https://doi.org/10.1177/1740774512455464